Literature DB >> 20086100

Control of cell survival and proliferation by mammalian eukaryotic initiation factor 4B.

David Shahbazian1, Armen Parsyan, Emmanuel Petroulakis, Ivan Topisirovic, Yvan Martineau, Bernard F Gibbs, Yuri Svitkin, Nahum Sonenberg.   

Abstract

Translation initiation plays an important role in cell growth, proliferation, and survival. The translation initiation factor eIF4B (eukaryotic initiation factor 4B) stimulates the RNA helicase activity of eIF4A in unwinding secondary structures in the 5' untranslated region (5'UTR) of the mRNA in vitro. Here, we studied the effects of eIF4B depletion in cells using RNA interference (RNAi). In agreement with the role of eIF4B in translation initiation, its depletion resulted in inhibition of this step. Selective reduction of translation was observed for mRNAs harboring strong to moderate secondary structures in their 5'UTRs. These mRNAs encode proteins, which function in cell proliferation (Cdc25C, c-myc, and ODC [ornithine decarboxylase]) and survival (Bcl-2 and XIAP [X-linked inhibitor of apoptosis]). Furthermore, eIF4B silencing led to decreased proliferation rates, promoted caspase-dependent apoptosis, and further sensitized cells to camptothecin-induced cell death. These results demonstrate that eIF4B is required for cell proliferation and survival by regulating the translation of proliferative and prosurvival mRNAs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20086100      PMCID: PMC2832492          DOI: 10.1128/MCB.01218-09

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  50 in total

Review 1.  BCL-2 family antagonists for cancer therapy.

Authors:  Guillaume Lessene; Peter E Czabotar; Peter M Colman
Journal:  Nat Rev Drug Discov       Date:  2008-12       Impact factor: 84.694

2.  DAP5 promotes cap-independent translation of Bcl-2 and CDK1 to facilitate cell survival during mitosis.

Authors:  Lea Marash; Noa Liberman; Sivan Henis-Korenblit; Gilad Sivan; Eran Reem; Orna Elroy-Stein; Adi Kimchi
Journal:  Mol Cell       Date:  2008-05-01       Impact factor: 17.970

3.  Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells.

Authors:  Mahvash Zakikhani; Ryan Dowling; I George Fantus; Nahum Sonenberg; Michael Pollak
Journal:  Cancer Res       Date:  2006-10-23       Impact factor: 12.701

Review 4.  Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.

Authors:  P J Roberts; C J Der
Journal:  Oncogene       Date:  2007-05-14       Impact factor: 9.867

5.  siRNA-mediated knockdown of Pdcd4 expression causes upregulation of p21(Waf1/Cip1) expression.

Authors:  N Bitomsky; N Wethkamp; R Marikkannu; K-H Klempnauer
Journal:  Oncogene       Date:  2008-04-21       Impact factor: 9.867

Review 6.  Drug discovery approaches targeting the PI3K/Akt pathway in cancer.

Authors:  C Garcia-Echeverria; W R Sellers
Journal:  Oncogene       Date:  2008-09-18       Impact factor: 9.867

Review 7.  IAP-targeted therapies for cancer.

Authors:  E C LaCasse; D J Mahoney; H H Cheung; S Plenchette; S Baird; R G Korneluk
Journal:  Oncogene       Date:  2008-10-20       Impact factor: 9.867

8.  Interactions between eIF4AI and its accessory factors eIF4B and eIF4H.

Authors:  Nadja Rozovsky; Aimee C Butterworth; Melissa J Moore
Journal:  RNA       Date:  2008-08-21       Impact factor: 4.942

9.  Response and determinants of cancer cell susceptibility to PI3K inhibitors: combined targeting of PI3K and Mek1 as an effective anticancer strategy.

Authors:  Ker Yu; Lourdes Toral-Barza; Celine Shi; Wei-Guo Zhang; Arie Zask
Journal:  Cancer Biol Ther       Date:  2007-11-21       Impact factor: 4.742

10.  Double inhibition of XIAP and Bcl-2 axis is beneficial for retrieving sensitivity of renal cell cancer to apoptosis.

Authors:  V Bilim; K Yuuki; T Itoi; A Muto; T Kato; A Nagaoka; T Motoyama; Y Tomita
Journal:  Br J Cancer       Date:  2008-02-19       Impact factor: 7.640

View more
  61 in total

Review 1.  Deconvoluting mTOR biology.

Authors:  Jason D Weber; David H Gutmann
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

Review 2.  mRNA helicases: the tacticians of translational control.

Authors:  Armen Parsyan; Yuri Svitkin; David Shahbazian; Christos Gkogkas; Paul Lasko; William C Merrick; Nahum Sonenberg
Journal:  Nat Rev Mol Cell Biol       Date:  2011-04       Impact factor: 94.444

3.  Comparative analysis of differentially expressed genes in Sika deer antler at different stages.

Authors:  Yu Zhao; Baojin Yao; Mei Zhang; Siming Wang; Hui Zhang; Wei Xiao
Journal:  Mol Biol Rep       Date:  2012-10-18       Impact factor: 2.316

Review 4.  Regulation of mRNA translation by signaling pathways.

Authors:  Philippe P Roux; Ivan Topisirovic
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-11-01       Impact factor: 10.005

5.  The translation initiation factor eIF3i up-regulates vascular endothelial growth factor A, accelerates cell proliferation, and promotes angiogenesis in embryonic development and tumorigenesis.

Authors:  Yike Yuan; Yaguang Zhang; Shaohua Yao; Huashan Shi; Xi Huang; Yuhao Li; Yuquan Wei; Shuo Lin
Journal:  J Biol Chem       Date:  2014-08-21       Impact factor: 5.157

6.  eIF4B stimulates translation of long mRNAs with structured 5' UTRs and low closed-loop potential but weak dependence on eIF4G.

Authors:  Neelam Dabas Sen; Fujun Zhou; Michael S Harris; Nicholas T Ingolia; Alan G Hinnebusch
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-06       Impact factor: 11.205

Review 7.  MYC and tumor metabolism: chicken and egg.

Authors:  Francesca R Dejure; Martin Eilers
Journal:  EMBO J       Date:  2017-11-10       Impact factor: 11.598

8.  The Pim-1 protein kinase is an important regulator of MET receptor tyrosine kinase levels and signaling.

Authors:  Bo Cen; Ying Xiong; Jin H Song; Sandeep Mahajan; Rachel DuPont; Kristen McEachern; Daniel J DeAngelo; Jorge E Cortes; Mark D Minden; Allen Ebens; Alice Mims; Amanda C LaRue; Andrew S Kraft
Journal:  Mol Cell Biol       Date:  2014-04-28       Impact factor: 4.272

9.  Mitotic MELK-eIF4B signaling controls protein synthesis and tumor cell survival.

Authors:  Yubao Wang; Michael Begley; Qing Li; Hai-Tsang Huang; Ana Lako; Michael J Eck; Nathanael S Gray; Timothy J Mitchison; Lewis C Cantley; Jean J Zhao
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-15       Impact factor: 11.205

Review 10.  Regulation of global and specific mRNA translation by the mTOR signaling pathway.

Authors:  Neethi Nandagopal; Philippe P Roux
Journal:  Translation (Austin)       Date:  2015-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.